Volitionrx Ltd (NYSE MKT:VNRX) — Market Cap & Net Worth
Market Cap & Net Worth: Volitionrx Ltd (VNRX)
Volitionrx Ltd (NYSE MKT:VNRX) has a market capitalization of $18.20 Million ($18.20 Million) as of May 22, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #25433 globally and #5235 in its home market, demonstrating a 14.41% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Volitionrx Ltd's stock price $2.70 by its total outstanding shares 8087955 (8.09 Million). Analyse how efficiently does Volitionrx Ltd generate cash to see how efficiently the company converts income to cash.
Volitionrx Ltd Market Cap History: 2015 to 2026
Volitionrx Ltd's market capitalization history from 2015 to 2026. Data shows change from $36.40 Million to $21.84 Million (-5.02% CAGR).
Volitionrx Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Volitionrx Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.20x
Volitionrx Ltd's market cap is 1.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $38.34 Million | $17.10K | -$16.10 Million | 2242.45x | N/A |
| 2020 | $31.46 Million | $13.43K | -$20.35 Million | 2342.15x | N/A |
| 2021 | $25.40 Million | $90.03K | -$26.81 Million | 282.07x | N/A |
| 2022 | $19.65 Million | $306.39K | -$30.27 Million | 64.15x | N/A |
| 2023 | $5.80 Million | $775.30K | -$35.32 Million | 7.48x | N/A |
| 2024 | $4.85 Million | $1.23 Million | -$26.97 Million | 3.93x | N/A |
| 2025 | $2.07 Million | $1.73 Million | -$23.36 Million | 1.20x | N/A |
Competitor Companies of VNRX by Market Capitalization
Companies near Volitionrx Ltd in the global market cap rankings as of May 22, 2026.
Key companies related to Volitionrx Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $152.62 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #198 globally with a market cap of $119.97 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #257 globally with a market cap of $97.77 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $152.62 Billion | $87.77 |
| #198 | Stryker Corporation | NYSE:SYK | $119.97 Billion | $313.50 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #257 | Medtronic PLC | NYSE:MDT | $97.77 Billion | $78.15 |
Volitionrx Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Volitionrx Ltd's market cap moved from $36.40 Million to $ 21.84 Million, with a yearly change of -5.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $21.84 Million | +956.34% |
| 2025 | $2.07 Million | -57.40% |
| 2024 | $4.85 Million | -16.32% |
| 2023 | $5.80 Million | -70.49% |
| 2022 | $19.65 Million | -22.61% |
| 2021 | $25.40 Million | -19.28% |
| 2020 | $31.46 Million | -17.93% |
| 2019 | $38.34 Million | +161.88% |
| 2018 | $14.64 Million | -38.44% |
| 2017 | $23.78 Million | -35.67% |
| 2016 | $36.96 Million | +1.56% |
| 2015 | $36.40 Million | -- |
End of Day Market Cap According to Different Sources
On May 22nd, 2026 the market cap of Volitionrx Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.20 Million USD |
| MoneyControl | $18.20 Million USD |
| MarketWatch | $18.20 Million USD |
| marketcap.company | $18.20 Million USD |
| Reuters | $18.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Volitionrx Ltd
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleos… Read more